85 related articles for article (PubMed ID: 2934024)
1. [An immunological study on the effect of simultaneous intrahepatic injection of an immunomodulator (OK-432) and adriamycin--an experiment in rats].
Takada T; Yasuda H; Uchiyama K; Hasegawa H; Miura S; Asagoe T; Hanaue H; Shikata J
Gan To Kagaku Ryoho; 1985 Dec; 12(12):2305-13. PubMed ID: 2934024
[TBL] [Abstract][Full Text] [Related]
2. [Immunological study on localized liver injection of immunopotentiator OK-432-- experimental studies in rats].
Takada T; Yasuda H; Uchiyama K; Hasegawa H
Gan To Kagaku Ryoho; 1984 Oct; 11(10):2267-71. PubMed ID: 6333213
[TBL] [Abstract][Full Text] [Related]
3. [Immunological study on localized intrahepatic injection of Adriamycin--experimental study in rats].
Takada T; Yasuda H; Uchiyama K; Hasegawa H
Gan To Kagaku Ryoho; 1985 Apr; 12(4):907-12. PubMed ID: 3157352
[TBL] [Abstract][Full Text] [Related]
4. Effects of oral administration of streptococcal preparation OK-432 on thoracic duct lymphocytes.
Hanaue H; Kim DY; Machimura T; Tsukui M; Kubota M; Kurosawa T; Shikata J; Kondoh Y; Ogoshi K; Makuuchi H
Tokai J Exp Clin Med; 1987 Sep; 12(3):159-65. PubMed ID: 3502615
[TBL] [Abstract][Full Text] [Related]
5. [The influence of a biological response modifier on thoracic lymphocytes--a study involving clinical cases and animal experiments].
Hanaue H; Kurosawa T; Miyakawa S; Kitano Y; Nemoto A; Yamoto H; Asagoe T; Shikata J
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1285-9. PubMed ID: 3488025
[TBL] [Abstract][Full Text] [Related]
6. [Intratumoral administration of OK432 in rats with liver tumor].
Ishimaru M
Nihon Geka Gakkai Zasshi; 1988 Jun; 89(6):880-8. PubMed ID: 2972906
[TBL] [Abstract][Full Text] [Related]
7. Decreased suppressor T-lymphocytes in women who received progestogen injections.
Sridama V; Limpongsanurak S; Sritippayawan S; Youngprapakorn S
J Med Assoc Thai; 1992 Aug; 75(8):479-82. PubMed ID: 1300365
[TBL] [Abstract][Full Text] [Related]
8. [Effect of combined use of radiation and twice intratumor administration of OK-432 at one week intervals against a murine fibrosarcoma (NFSA)].
Mukai M; Ando K; Koike S
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):631-5. PubMed ID: 3355184
[TBL] [Abstract][Full Text] [Related]
9. Effects of oral lentinan on T-cell subsets in peripheral venous blood.
Hanaue H; Tokuda Y; Machimura T; Kamijoh A; Kondo Y; Ogoshi K; Makuuchi H; Nakasaki H; Tajima T; Mitomi T
Clin Ther; 1989; 11(5):614-22. PubMed ID: 2529966
[TBL] [Abstract][Full Text] [Related]
10. Altered levels of mononuclear leukocytes in tumor-bearing rats: decrease of helper T lymphocytes and increase of suppressor cells.
Fernandez-Cruz E; Gilman SC; Feldman JD
J Immunol; 1982 Sep; 129(3):1324-8. PubMed ID: 6213711
[TBL] [Abstract][Full Text] [Related]
11. W3/25+ T cells mediate the induction of immunologic unresponsiveness in enhanced rat recipients of cardiac allografts.
Padberg WM; Kupiec-Weglinski JW; Lord RH; Araneda DH; Tilney NL
J Immunol; 1987 Jun; 138(11):3669-74. PubMed ID: 2953786
[TBL] [Abstract][Full Text] [Related]
12. Effects of biological response modifier on thoracic duct lymphocytes in recurrent gastric cancer. Evaluation of OK-432, a hemolytic streptococcus preparation.
Hanaue H; Kim DY; Kubota M; Kurosawa T; Shikata J; Kondoh Y; Ogoshi K; Makuuchi H; Nakasaki H; Mitomi T
Tokai J Exp Clin Med; 1987 May; 12(2):97-102. PubMed ID: 3502432
[TBL] [Abstract][Full Text] [Related]
13. [Combination of CD4+ CD25+ regulatory T cell and costimulatory pathway blockade inhibits acute rejection after liver transplantation: experiment with rats].
Shi LB; Zhang HW; Peng CH
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):942-6. PubMed ID: 17650415
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte profiles in patients with chronic low back pain enrolled in a clinical trial.
Brennan PC; Graham MA; Triano JJ; Hondras MA; Anderson RJ
J Manipulative Physiol Ther; 1994 May; 17(4):219-27. PubMed ID: 8046277
[TBL] [Abstract][Full Text] [Related]
15. The influence of chrysotherapy on T-lymphocyte subpopulations in rheumatoid arthritis.
Pfreundschuh M; Parino G; Gram N; Bröker A; Gause A; Hunstein W
Z Rheumatol; 1983; 42(6):328-31. PubMed ID: 6229937
[TBL] [Abstract][Full Text] [Related]
16. [A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)].
Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):997-1012. PubMed ID: 2202770
[TBL] [Abstract][Full Text] [Related]
17. Systemic administration of human leukocyte interferon to melanoma patients. III. Increased helper:suppressor cell ratios in melanoma patients during interferon treatment.
Karavodin LM; Golub SH
Nat Immun Cell Growth Regul; 1983-1984; 3(4):193-202. PubMed ID: 6241293
[TBL] [Abstract][Full Text] [Related]
18. [Local immunotherapy with OK-432 for malignant gliomas--immunohistochemical analysis of chronological changes of tumor tissues].
Saito T; Tanaka R; Sekiguchi K; Yoshida S; Washiyama K; Yamada N; Takeda N
No To Shinkei; 1988 Jul; 40(7):609-15. PubMed ID: 3224036
[TBL] [Abstract][Full Text] [Related]
19. Helper and suppressor T lymphocyte function in severe alcoholic liver disease.
McKeever U; O'Mahony C; Whelan CA; Weir DG; Feighery C
Clin Exp Immunol; 1985 Apr; 60(1):39-48. PubMed ID: 3159525
[TBL] [Abstract][Full Text] [Related]
20. [Endoscopic preoperative intralesional injection of OK-432 in early gastric cancer].
Yamane T; Sagara Y; Suzuki G; Kasuga M; Sakita M; Fujita Y; Majima S
Gan To Kagaku Ryoho; 1984 Apr; 11(4):930-4. PubMed ID: 6721507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
